| PERIOD ENDING | 29-Mar-09 | 30-Mar-08 | 1-Apr-07 | | Total Revenue | 305,607 | 296,946 | 272,649 | | Cost of Revenue | 261,568 | 251,266 | 225,507 | | | Gross Profit | 44,039 | 45,680 | 47,142 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 30,289 | 28,092 | 23,811 | | Non Recurring | 23,670 |
-
| 1,535 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (9,920) | 17,588 | 21,796 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 270 | 465 | | Earnings Before Interest And Taxes | (9,920) | 17,858 | 22,261 | | Interest Expense | 848 |
-
|
-
| | Income Before Tax | (10,768) | 17,858 | 22,261 | | Income Tax Expense | (5,703) | 5,065 | 7,766 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,065) | 12,793 | 14,495 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,065) | 12,793 | 14,495 | | Preferred Stock And Other Adjustments | (1,087) | (1,084) | (1,104) | | | Net Income Applicable To Common Shares | ($6,152) | $11,709 | $13,391 |
|
0.11% Nasdaq 
0.07 (1.93%) 
Income Statement
